0001209191-22-062657.txt : 20221223
0001209191-22-062657.hdr.sgml : 20221223
20221223171302
ACCESSION NUMBER: 0001209191-22-062657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221201
FILED AS OF DATE: 20221223
DATE AS OF CHANGE: 20221223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Caroline
CENTRAL INDEX KEY: 0001684087
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 221486079
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE, SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-01
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001684087
Young Caroline
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2022-12-01
4
P
0
20
2.33
A
19228
D
Common Stock
2022-12-02
4
P
0
20
2.31
A
19248
D
Common Stock
2022-12-05
4
P
0
20
2.19
A
19268
D
Common Stock
2022-12-06
4
P
0
20
2.19
A
19288
D
Common Stock
2022-12-07
4
P
0
20
2.18
A
19308
D
Common Stock
2022-12-08
4
P
0
20
2.19
A
19328
D
Common Stock
2022-12-09
4
P
0
20
2.15
A
19348
D
Common Stock
2022-12-12
4
P
0
20
2.14
A
19368
D
Common Stock
2022-12-13
4
P
0
20
2.18
A
19388
D
Common Stock
2022-12-14
4
P
0
20
2.21
A
19408
D
Common Stock
2022-12-15
4
P
0
20
2.24
A
19428
D
Common Stock
2022-12-16
4
P
0
20
2.22
A
19448
D
Common Stock
2022-12-19
4
P
0
30
2.21
A
19478
D
Common Stock
2022-12-20
4
P
0
109
2.31
A
19587
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Caroline Young by /s/ John Hamm as attorney-in-fact
2022-12-23